Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2900823 | Chest | 2013 | 11 Pages |
Abstract
Patients with mutations in NKX2-1 may present with pulmonary manifestations in the newborn period or during childhood when thyroid or neurologic abnormalities are not apparent. Surfactant dysfunction and, in more severe cases, disrupted lung development are likely mechanisms for the respiratory disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Aaron MD, Robin R. MD, Susan E. PhD, Frances V. MD, Megan K. MD, Danielle N. MD, Ann C. MD, Benjamin MD, Mark J. MD, Derek A. MD, Lee D. MD, Jill A. MS, Robert Roger MD, Lisa R. MD, F. Sessions MD, Lawrence M. MD,